Nurix Therapeutics (NRIX) News Today $22.92 -3.94 (-14.67%) (As of 11/15/2024 ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period Nurix Therapeutics (NASDAQ:NRIX) Shares Down 8.7% - Should You Sell?Nurix Therapeutics (NASDAQ:NRIX) Trading Down 8.7% - Here's WhyNovember 15 at 1:37 PM | marketbeat.comARK Investment Management LLC Sells 106,967 Shares of Nurix Therapeutics, Inc. (NASDAQ:NRIX)ARK Investment Management LLC lowered its holdings in shares of Nurix Therapeutics, Inc. (NASDAQ:NRIX - Free Report) by 4.6% during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 2,216,365 shares ofNovember 8, 2024 | marketbeat.comNurix Therapeutics (NASDAQ:NRIX) Hits New 52-Week High - Here's WhyNurix Therapeutics (NASDAQ:NRIX) Sets New 12-Month High - Should You Buy?November 7, 2024 | marketbeat.comPromising Efficacy and Safety of Nurix Therapeutics’ NX-5948 Justifies Buy RatingNovember 7, 2024 | markets.businessinsider.comNurix Therapeutics' (NRIX) Buy Rating Reaffirmed at Needham & Company LLCNeedham & Company LLC reiterated a "buy" rating and issued a $29.00 price objective on shares of Nurix Therapeutics in a research report on Wednesday.November 6, 2024 | marketbeat.comNurix Therapeutics Announces Presentations at the 66th American Society of Hematology (ASH) Annual MeetingNovember 5, 2024 | finance.yahoo.comNurix Therapeutics, Inc. (NASDAQ:NRIX) CFO Sells $86,096.88 in StockNovember 2, 2024 | insidertrades.comHoute Hans Van Sells 3,546 Shares of Nurix Therapeutics, Inc. (NASDAQ:NRIX) StockNurix Therapeutics, Inc. (NASDAQ:NRIX - Get Free Report) CFO Houte Hans Van sold 3,546 shares of the company's stock in a transaction on Friday, November 1st. The shares were sold at an average price of $24.28, for a total transaction of $86,096.88. Following the completion of the sale, the chief financial officer now directly owns 33,724 shares in the company, valued at $818,818.72. This represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link.November 1, 2024 | marketbeat.comTracking Cathie Wood's ARK Invest 13F Portfolio - Q3 2024 UpdateNovember 1, 2024 | seekingalpha.comNurix Therapeutics to Participate in Upcoming Investor ConferencesOctober 31, 2024 | globenewswire.comInsider Selling: Nurix Therapeutics, Inc. (NASDAQ:NRIX) CFO Sells 2,368 Shares of StockOctober 31, 2024 | insidertrades.comAllspring Global Investments Holdings LLC Makes New $3.15 Million Investment in Nurix Therapeutics, Inc. (NASDAQ:NRIX)Allspring Global Investments Holdings LLC acquired a new stake in shares of Nurix Therapeutics, Inc. (NASDAQ:NRIX - Free Report) during the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The firm acquired 140,273 shares of the company's stock, valued at approximatOctober 30, 2024 | marketbeat.comNurix Therapeutics, Inc. (NASDAQ:NRIX) Given Average Rating of "Moderate Buy" by BrokeragesNurix Therapeutics, Inc. (NASDAQ:NRIX - Get Free Report) has been assigned an average rating of "Moderate Buy" from the fifteen ratings firms that are covering the company, Marketbeat Ratings reports. One analyst has rated the stock with a hold rating and fourteen have given a buy rating to the cOctober 28, 2024 | marketbeat.comUBS Initiates Coverage of Nurix Therapeutics (NRIX) with Buy RecommendationOctober 25, 2024 | msn.comNurix Therapeutics (NASDAQ:NRIX) Reaches New 1-Year High - Here's What HappenedNurix Therapeutics (NASDAQ:NRIX) Reaches New 1-Year High - Here's WhyOctober 25, 2024 | marketbeat.comNurix Therapeutics initiated with a Buy at UBSOctober 24, 2024 | markets.businessinsider.comUBS Group Begins Coverage on Nurix Therapeutics (NASDAQ:NRIX)UBS Group assumed coverage on Nurix Therapeutics in a report on Thursday. They set a "buy" rating and a $35.00 target price on the stock.October 24, 2024 | marketbeat.comBarclays Gives a Buy Rating to Nurix Therapeutics (NRIX)October 24, 2024 | markets.businessinsider.comFY2024 EPS Forecast for Nurix Therapeutics Raised by AnalystNurix Therapeutics, Inc. (NASDAQ:NRIX - Free Report) - HC Wainwright lifted their FY2024 earnings per share (EPS) estimates for shares of Nurix Therapeutics in a note issued to investors on Monday, October 21st. HC Wainwright analyst R. Burns now anticipates that the company will post earnings ofOctober 23, 2024 | marketbeat.comNurix Therapeutics Announces Presentations at the 7th Annual TPD & Induced Proximity SummitOctober 21, 2024 | globenewswire.comPromising Data on Nurix Therapeutics’ NX-5948 Supports Buy Rating for Waldenstrom’s Macroglobulinemia TreatmentOctober 21, 2024 | markets.businessinsider.comAnalysts Are Bullish on Top Healthcare Stocks: Nurix Therapeutics (NRIX), Ascendis Pharma (ASND)October 21, 2024 | markets.businessinsider.comNurix Therapeutics (NASDAQ:NRIX) Receives "Buy" Rating from Needham & Company LLCNeedham & Company LLC reissued a "buy" rating and set a $29.00 target price on shares of Nurix Therapeutics in a report on Monday.October 21, 2024 | marketbeat.comWestHill Financial Advisors Inc. Has $5.36 Million Stock Position in Nurix Therapeutics, Inc. (NASDAQ:NRIX)WestHill Financial Advisors Inc. reduced its position in shares of Nurix Therapeutics, Inc. (NASDAQ:NRIX - Free Report) by 15.9% in the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 238,333 shares of the company's stock after selling 45October 20, 2024 | marketbeat.comNurix Reports Positive Results For BTK Degrader NX-5948 In Waldenstrom's MacroglobulinemiaOctober 20, 2024 | markets.businessinsider.comNurix Therapeutics Presents Positive Results from the Ongoing Clinical Trial of Its BTK Degrader NX-5948 in Patients with Relapsed/Refractory Waldenstrom's MacroglobulinemiaOctober 19, 2024 | globenewswire.comNurix Therapeutics (NASDAQ:NRIX) Reaches New 52-Week High - Here's What HappenedNurix Therapeutics (NASDAQ:NRIX) Sets New 52-Week High - Here's WhyOctober 17, 2024 | marketbeat.comNurix Therapeutics Expands Its Board of Directors with the Addition of Drug Commercialization Expert Anil KapurOctober 16, 2024 | globenewswire.comNurix Therapeutics, Inc. (NASDAQ:NRIX) Insider Sells $82,250.00 in StockOctober 16, 2024 | insidertrades.comSG Americas Securities LLC Sells 80,254 Shares of Nurix Therapeutics, Inc. (NASDAQ:NRIX)SG Americas Securities LLC reduced its holdings in Nurix Therapeutics, Inc. (NASDAQ:NRIX - Free Report) by 77.8% during the third quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 22,945 shares of the company's stock after selling 80,254October 16, 2024 | marketbeat.comAnalysts Conflicted on These Healthcare Names: Penumbra (PEN), Nurix Therapeutics (NRIX) and Charles River Labs (CRL)October 16, 2024 | markets.businessinsider.comTruist Financial Remains a Buy on Nurix Therapeutics (NRIX)October 14, 2024 | markets.businessinsider.comNurix Therapeutics (NRIX) Receives a Buy from Piper SandlerOctober 14, 2024 | markets.businessinsider.comNurix Therapeutics (NASDAQ:NRIX) Stock Price Up 4.6% - Here's WhyNurix Therapeutics (NASDAQ:NRIX) Shares Up 4.6% - Here's What HappenedOctober 14, 2024 | marketbeat.comNurix Therapeutics (NASDAQ:NRIX) Rating Reiterated by StephensStephens reiterated an "overweight" rating and issued a $31.00 price objective on shares of Nurix Therapeutics in a research note on Monday.October 14, 2024 | marketbeat.comNurix Therapeutics (NASDAQ:NRIX) Releases Quarterly Earnings ResultsNurix Therapeutics (NASDAQ:NRIX - Get Free Report) announced its quarterly earnings data on Friday. The company reported ($0.67) earnings per share (EPS) for the quarter, meeting analysts' consensus estimates of ($0.67). The business had revenue of $12.59 million during the quarter, compared to analysts' expectations of $13.85 million. Nurix Therapeutics had a negative return on equity of 67.78% and a negative net margin of 264.84%.October 14, 2024 | marketbeat.comUnveiling 6 Analyst Insights On Nurix TherapeuticsOctober 11, 2024 | benzinga.comJefferies Initiates Coverage of Nurix Therapeutics (NRIX) with Buy RecommendationOctober 11, 2024 | msn.comNurix Therapeutics Reports Third Quarter Fiscal 2024 Financial Results and Provides a Corporate UpdateOctober 11, 2024 | globenewswire.comNurix Therapeutics (NASDAQ:NRIX) Shares Gap Up - Time to Buy?Nurix Therapeutics (NASDAQ:NRIX) Shares Gap Up - Here's WhyOctober 11, 2024 | marketbeat.comNurix Therapeutics (NASDAQ:NRIX) Now Covered by Jefferies Financial GroupJefferies Financial Group initiated coverage on shares of Nurix Therapeutics in a report on Friday. They issued a "buy" rating and a $41.00 price target on the stock.October 11, 2024 | marketbeat.comNurix Therapeutics (NASDAQ:NRIX) Stock Quotes, Forecast and News SummaryOctober 11, 2024 | benzinga.comNurix Therapeutics (NASDAQ:NRIX) Sees Large Volume Increase - Still a Buy?Nurix Therapeutics (NASDAQ:NRIX) Sees Strong Trading Volume - Time to Buy?October 10, 2024 | marketbeat.comNurix Therapeutics Announces Presentations at ACR Convergence 2024, the Annual Meeting of the American College of RheumatologyOctober 9, 2024 | globenewswire.com28,784 Shares in Nurix Therapeutics, Inc. (NASDAQ:NRIX) Bought by Squarepoint Ops LLCSquarepoint Ops LLC acquired a new stake in shares of Nurix Therapeutics, Inc. (NASDAQ:NRIX - Free Report) during the second quarter, according to its most recent Form 13F filing with the SEC. The fund acquired 28,784 shares of the company's stock, valued at approximately $601,000. Squarepoint OpsOctober 9, 2024 | marketbeat.comNurix Therapeutics (NASDAQ:NRIX) Stock Price Up 3.9% - Here's What HappenedNurix Therapeutics (NASDAQ:NRIX) Trading 3.9% Higher - What's Next?October 8, 2024 | marketbeat.comNurix: An Attractive Early-Stage Biotech PlayOctober 8, 2024 | seekingalpha.comNurix Therapeutics, Inc. (NASDAQ:NRIX) Shares Acquired by Millennium Management LLCMillennium Management LLC lifted its position in Nurix Therapeutics, Inc. (NASDAQ:NRIX - Free Report) by 60.2% during the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 599,623 shares of the company's stock after acqOctober 8, 2024 | marketbeat.comTeachers Retirement System of The State of Kentucky Takes $578,000 Position in Nurix Therapeutics, Inc. (NASDAQ:NRIX)Teachers Retirement System of The State of Kentucky acquired a new position in Nurix Therapeutics, Inc. (NASDAQ:NRIX - Free Report) in the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor acquired 27,695 shares of the compOctober 6, 2024 | marketbeat.comAmerican Century Companies Inc. Sells 49,942 Shares of Nurix Therapeutics, Inc. (NASDAQ:NRIX)American Century Companies Inc. decreased its stake in Nurix Therapeutics, Inc. (NASDAQ:NRIX - Free Report) by 83.1% in the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 10,124 shares of the company's stockOctober 5, 2024 | marketbeat.com Get Nurix Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for NRIX and its competitors with MarketBeat's FREE daily newsletter. Email Address The centerpiece of Trump’s crypto’s masterplan … (Ad)Donald Trump wants to be America’s first crypto president. He was the keynote speaker at the recent Bitcoin conference in Nashville … Where he told an adoring crowd that the U.S. would become … “The crypto capital of the planet and the Bitcoin superpower of the world.” Click here to find out more about what could be Trump and JD Vance’s favorite coin. NRIX Media Mentions By Week NRIX Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. NRIX News Sentiment▼1.270.55▲Average Medical News Sentiment NRIX News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. NRIX Articles This Week▼25▲NRIX Articles Average Week Get Nurix Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for NRIX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies ARVN News LGND News PRAX News CMPS News VKTX News LEGN News ASND News ELAN News CYTK News BPMC News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:NRIX) was last updated on 11/17/2024 by MarketBeat.com Staff From Our PartnersBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredThere is a little known company that is changing warfareWith geo - political instability around the world investors are flocking to defense contract stocks. There...Reticulate | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredThe pin that pops the AI bubbleMy new documentary explores the background to this pattern and how and why I believe it will almost certainly ...Porter & Company | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredTrump Wins… But Elon Says Get Ready to BraceTrump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...Genesis Gold Group | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Nurix Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Nurix Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free NRIX Stock Alerts